[Gynecomastia-galactorrhea during treatment with mirtazapine].
Lynch
A
A
Madjlessi
A
A
D000368:Aged; D000369:Aged, 80 and over; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005687:Galactorrhea / Q000139:chemically induced* / Q000175:diagnosis; D006177:Gynecomastia / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000175:diagnosis; D008297:Male; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D017374:Paroxetine; D000078785:Mirtazapine